C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure Nuburu Q3 2023 Earnings Narrowed Loss and Strategic Progress Drive Sentiment BWEN Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Rally Blackbaud Q1 2026 Earnings Modest EPS Beat Reflects Steady Execution SPXC Q1 2026 Earnings EPS Beats Expectations by 59